# The Use of Pentoxifylline and Vitamin E in the Treatment of Chronic Breast Pain

> **NCT00188669** · PHASE2 · TERMINATED · sponsor: **University Health Network, Toronto** · enrollment: 48 (estimated)

## Conditions studied

- Breast Neoplasms

## Interventions

- **DRUG:** pentoxifylline
- **DRUG:** alpha-Tocopherol

## Key facts

- **NCT ID:** NCT00188669
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2002-07
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 48 (ESTIMATED)
- **Why stopped:** date: August 2006. No annual renewal
- **Last updated:** 2010-08-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00188669

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00188669, "The Use of Pentoxifylline and Vitamin E in the Treatment of Chronic Breast Pain". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00188669. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*